Search for: "Takeda Pharmaceuticals" Results 21 - 40 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2020, 6:30 am by Andrew Hamm
Takeda Pharmaceutical Co. v. [read post]
30 Mar 2020, 7:34 am by Deb Givens
  EU antitrust regulators have opened a full investigation into Johnson & Johnson’s acquisition of Takeda Pharmaceutical’s surgical patch product TachoSil, concerned that the deal could lead to reduced choice and higher prices for customers. [read post]
4 Mar 2020, 7:11 am by Wim Vandenberghe
The Innovative Medicines Initiative (IMI) was created in 2008 as a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).[1] Its overall goal is to increase the competitiveness of R&D in the European pharmaceutical sector by encouraging companies to work with each other and with the public sector. [read post]
19 Dec 2019, 9:41 am
  In his reference, the Judge trotted through the English court's and CJEU's case law Article 3(a) - Takeda, Farmitalia, Daiichi, Yeda, Medeva (and its progeny), Actavis v Sanofi, Eli Lilly v HGS, Actavis v Boehringer, - and found that it was clear that something more was required, but what that "something" was was not clear. [read post]
13 Nov 2019, 12:23 pm by Tom Lamb
Here is a list of our earlier 2019 Uloric articles: Uloric Lawsuits Involving Heart Attacks And Strokes Follow Recent FDA Warnings About Cardiovascular Deaths (April 2019) Uloric "Black-Box Warning" For Increased Risks Of Heart-Related Deaths And Cardiovascular Side Effects (March 2019) Uloric Recall, "Black-Box Warning", And Limited Use Discussed By FDA Advisory Committees In January 2019 (January 2019) We are investigating Uloric drug injury cases against… [read post]
7 Nov 2019, 8:10 pm by Patent Docs
Noonan -- As reported in John Carrol's EndPoint News early last month, GlobalData has published a list of the Top 20 Pharmaceutical Companies by market cap as of March 31, 2019. [read post]
10 Sep 2019, 3:31 pm
. | Book Review: Unified Patent Protection in Europe | Tragic news: Professor Shamnad Basheer has passed away | Remembering Shamnad Basheer | WIPO launched its first program on IP for indigenous women | IP Tribunal of SPC opens first circuit trial in July 2019Never Too Late 229  [Week ending 4 August] Takeda v Roche: 'Is it plausible? [read post]
4 Sep 2019, 7:00 am by silverman_admin
The pharmaceutical companies have the responsibility to keep the public safe. [read post]
26 Aug 2019, 12:09 pm
. | Book Review: Unified Patent Protection in Europe | Tragic news: Professor Shamnad Basheer has passed away | Remembering Shamnad Basheer | WIPO launched its first program on IP for indigenous women | IP Tribunal of SPC opens first circuit trial in July 2019Never Too Late 229  [Week ending 4 August] Takeda v Roche: 'Is it plausible? [read post]
13 Aug 2019, 6:03 am
SpecialKat Tian Lu reports in IP Tribunal of SPC opens first circuit trail in July 2019 on the first circuit trial of the IP Tribunal within the Supreme People’s Court of China and explains the reasons for the establishment of this court.PREVIOUSLY ON NEVER TOO LATE Never Too Late 229 [Week ending 4 August] Takeda v Roche: "Is it plausible? [read post]
7 Aug 2019, 12:43 am
PatentsIn Takeda v Roche: "Is it plausible? [read post]
1 Aug 2019, 2:14 am
Earlier this year, the UK courts considered the validity of Genentech's patent for Taltz, an anti-IL-17 monoclonal antibody (IPKat post here), and last month, the courts considered Pfizer's request for an Arrow declaration relating to Roche's monoclonal antibody drug Avastin (bevacizumab) (IPKat post here).The latest UK High Court patent decision (Takeda v Roche [2019] EWHC 1911) relates to another pair of pharmaceutical company giants… [read post]
23 Jul 2019, 7:38 am by Brian Cordery
This included chimeric, humanized or human antibodies and each could be made into a pharmaceutical composition comprising such antibodies. [read post]
7 Jul 2019, 7:38 am by Dan Bressler
” “Takeda loses ‘spurious’ bid to DQ Baker Botts in antitrust case” — “Takeda Pharmaceutical Company on Thursday lost a bid to disqualify Baker Botts from representing generic drug company Zydus Pharmaceuticals Inc in a lawsuit accusing Takeda of an antitrust violation. [read post]
5 Jun 2019, 6:45 am by John Jascob
Karuna, whose founders worked at Eli Lilly and Takeda Pharmaceuticals, makes medicines to address neuropsychiatric conditions. [read post]
30 Apr 2019, 7:22 am
  Prior to 2017, Canada had been the only G7 nation not to provide patent term extension for pharmaceutical products and was pressured into adopting this by the EU. [read post]
29 Apr 2019, 1:55 pm by Tom Lamb
February 2019 Uloric Label Changes Include New "Black-Box Warning" To The Effect That Uloric Is Gout Drug Of Last Resort   (Posted by Tom Lamb at DrugInjuryWatch.com)   As a result of recent FDA-mandated label changes for Uloric there have been lawsuits filed against Takeda Pharmaceuticals America, Inc., the manufacturer of Uloric. [read post]